NCT02356224View on ClinicalTrials.gov

The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Type 2 Diabetes
Interventions
DRUG

SHR3824

A tablet of 2.5 mg, 5 mg, 10 mg, 25 mg, 50mg, 100mg, 200 of SHR3824 taken for single dose.

DRUG

Placebo

A tablet of 2.5 mg, 5 mg, 10 mg, 25 mg, 50mg, 100mg, 200 of Placebo taken for single dose.

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02356224 - The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers | Biotech Hunter | Biotech Hunter